SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001600620-24-000014
Filing Date
2024-02-22
Accepted
2024-02-22 16:17:28
Documents
1
Period of Report
2023-03-02

Document Format Files

Seq Description Document Type Size
1 FORM 4/A wk-form4a_1708636621.html 4/A  
1 FORM 4/A wk-form4a_1708636621.xml 4/A 3524
  Complete submission text file 0001600620-24-000014.txt   4951
Mailing Address #140, 14315 - 118 AVENUE EDMONTON A0 T5L 4S6
Business Address #140, 14315 - 118 AVENUE EDMONTON A0 T5L 4S6 250-744-2487
Aurinia Pharmaceuticals Inc. (Issuer) CIK: 0001600620 (see all company filings)

IRS No.: 981231763 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O CERECOR INC. 400 EAST PRATT STREET, SUITE 606 BALTIMORE MD 21202
Business Address
Miller Joseph M (Reporting) CIK: 0001746372 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-36421 | Film No.: 24665032